Complications After CT-guided Lung Biopsies at St. Olavs Hospital

At St. Olavs Hospital, a prospective collection of data on complications related to CT-guided lung biopsies has been conducted over several years as part of quality control study. The primary aim of this quality control study is to map complications in all patients who have undergone percutaneous CT-guided lung biopsy at St. Olavs Hospital from May 2012 to December 2023.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pneumothorax Iatrogenic Postprocedural Air Embolism as A Complication of Medical Care Hemoptysis Hemorrhage Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Pathologic Processes Pathological Conditions, Signs and Symptoms Respiratory Tract Diseases Respiratory Tract Neoplasms Signs and Symptoms Signs and Symptoms, Respiratory Thoracic Neoplasms

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients eligible to a CT-guided needle biopsy of a lung nodule (allcomers)

Exclusion criteria

None

Treatment and study plan

CT-guided needle biopsy of lung nodule

Procedure

This is a simple needle biopsy of lung nodules guided with CT imaging

Primary outcomes

Pneumothorax

Time frame: Patients are assessed with a CT scan 5 minutes after the lung biopsy

The frequency of pneumothorax after lung biopsy
Lung bleeding

Time frame: Patiens are assessed with a CT scan 5 minutes after the procedure

How frequent is parenchymal bleeding after lung biopsy

Secondary outcomes

Factors associated with complications after lung biopsy

Time frame: All patiens are assessed with CT scan 5 minutes after the lung biopsy

Analyse possible factors leading to complications after lung biopsies

Sponsors and collaborators

Lead sponsor

St. Olavs Hospital

Other

Registry information

Acronym: KELSO

Important dates

Study start: 2012
Primary completion: 2023
Study completion: 2023
First posted: Apr 14, 2026
Registry last updated: Apr 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed